PE39599A1 - Dispositivo de inhalacion - Google Patents

Dispositivo de inhalacion

Info

Publication number
PE39599A1
PE39599A1 PE1998000011A PE00001198A PE39599A1 PE 39599 A1 PE39599 A1 PE 39599A1 PE 1998000011 A PE1998000011 A PE 1998000011A PE 00001198 A PE00001198 A PE 00001198A PE 39599 A1 PE39599 A1 PE 39599A1
Authority
PE
Peru
Prior art keywords
dosage
dose
deposit
user
communicated
Prior art date
Application number
PE1998000011A
Other languages
English (en)
Inventor
Peter John Brand
Etienne Seguelas
Bosko Dmitrovic
David Buday-Goldberger
Paul Kenneth Rand
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PE39599A1 publication Critical patent/PE39599A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A61M15/0068—Indicating or counting the number of dispensed doses or of remaining doses
    • A61M15/007—Mechanical counters
    • A61M15/0071—Mechanical counters having a display or indicator
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Abstract

QUE COMPRENDE: A) UN CUERPO QUE DEFINE UN DEPOSITO PARA MEDICAMENTO EN LA FORMA DE UN POLVO; B) UNA SALIDA A TRAVES DE LA CUAL UN USUARIO PUEDE INHALAR; Y C) UN MIEMBRO DE DOSIFICACION, CON AL MENOS UN REBAJO DE DOSIFICACION FORMADO EN EL MISMO, QUE ES MOVIBLE ENTRE UNA PRIMERA POSICION EN LA CUAL AL MENOS UN REBAJO DE DOSIFICACION SE COMUNICA CON EL DEPOSITO PARA RECIBIR UNA DOSIS DE POLVO DESDE EL MISMO, Y UNA SEGUNDA POSICION EN LA CUAL AL MENOS UN REBAJO DE DOSIFICACION SE COMUNICA CON LA SALIDA PARA PERMITIR AL USUARIO INHALAR LA DOSIS, ADEMAS AL MENOS UN REBAJO DE DOSIFICACION ESTA FORMADO EN UNA CARA O SUPERFICIE DEL MIEMBRO DE DOSIFICACION QUE SE PRESIONA PARA PONERSE EN CONTACTO CONTRA UNA SUPERFICIE O CARA DE ACOPLAMIENTO SIMILAR DEL CUERPO EN EL EXTREMO INFERIOR DEL DEPOSITO PARA FORMAR UN SELLO DINAMICO, CARACTERIZADO EN QUE AL MENOS UNA DE DICHAS CARAS O SUPERFICIES SE HACE DE UN MATERIAL FLEXIBLE QUE TIENE UNA DUREZA DE MENOS DE 80 SHORE A Y UN COEFICIENTE DE FRICCION DE 0,4 O MENOS. DICHO DISPOSITIVO SE USA PARA DISPERSAR DOSIS MEDIDAS DE MEDICAMENTO EN LA FORMA DE POLVO A UN USUARIO
PE1998000011A 1997-01-08 1998-01-06 Dispositivo de inhalacion PE39599A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700226.5A GB9700226D0 (en) 1997-01-08 1997-01-08 Inhalation device

Publications (1)

Publication Number Publication Date
PE39599A1 true PE39599A1 (es) 1999-05-05

Family

ID=10805635

Family Applications (2)

Application Number Title Priority Date Filing Date
PE1998000011A PE39599A1 (es) 1997-01-08 1998-01-06 Dispositivo de inhalacion
PE2001000783A PE20030179A1 (es) 1997-01-08 2001-08-07 Dispositivo de inhalacion

Family Applications After (1)

Application Number Title Priority Date Filing Date
PE2001000783A PE20030179A1 (es) 1997-01-08 2001-08-07 Dispositivo de inhalacion

Country Status (28)

Country Link
US (1) US6321747B1 (es)
EP (2) EP0954348B1 (es)
JP (1) JP2001507966A (es)
KR (1) KR20000069973A (es)
CN (2) CN1249694A (es)
AP (2) AP1165A (es)
AR (2) AR011372A1 (es)
AT (2) ATE279954T1 (es)
BR (1) BR9806864A (es)
CA (1) CA2277150A1 (es)
CO (1) CO5080756A1 (es)
CZ (1) CZ2000298A3 (es)
DE (2) DE69827112T2 (es)
EA (2) EA001286B1 (es)
GB (1) GB9700226D0 (es)
HR (1) HRP980382B1 (es)
HU (1) HU222771B1 (es)
ID (1) ID22851A (es)
IL (1) IL130687A (es)
IS (1) IS5103A (es)
NO (1) NO993348L (es)
NZ (1) NZ336507A (es)
PE (2) PE39599A1 (es)
PL (2) PL187815B1 (es)
TR (2) TR199901582T2 (es)
TW (1) TW404843B (es)
WO (1) WO1998030262A2 (es)
YU (1) YU32399A (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9701957A (es) * 1994-09-16 1998-02-28 Glaxo Wellcome Lab Sa Dispostivo de inhalacion.
JPH11122624A (ja) 1997-10-16 1999-04-30 Matsushita Electric Ind Co Ltd ビデオデコーダ処理量を低減する方法および装置
ES2241611T3 (es) * 1999-06-05 2005-11-01 Innovata Biomed Limited Sisstema de suministro de medicamentos.
GB9920839D0 (en) 1999-09-04 1999-11-10 Innovata Biomed Ltd Inhaler
DE19961300A1 (de) 1999-12-18 2001-06-21 Asta Medica Ag Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator
JP2003531123A (ja) * 2000-04-13 2003-10-21 イノバータ・バイオミッド・リミテッド 医薬品
GB0015034D0 (en) 2000-06-21 2000-08-09 Glaxo Group Ltd Inhalation device
TWI224513B (en) * 2000-06-23 2004-12-01 Norton Healthcare Ltd Dose counter for medicament inhaler
GB0019715D0 (en) 2000-08-10 2000-09-27 Pa Consulting Services Device for delivering physiologically active agent in powdered form
SE517229C2 (sv) * 2000-09-25 2002-05-14 Microdrug Ag Kontinuerlig inhalator för torrt pulver
GB0109717D0 (en) * 2001-04-20 2001-06-13 Glaxo Group Ltd Medicament dispenser
FI20011317A0 (fi) 2001-06-20 2001-06-20 Orion Corp Jauheinhalaattori
EP1416990A1 (en) * 2001-08-09 2004-05-12 Glaxo Group Limited Inhalation device with a pharmaceutical composition
CA2460904C (en) * 2001-09-19 2011-03-22 Advent Pharmaceuticals Pty Ltd An inhaler for delivering metered doses of powdered medicament
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
US7258118B2 (en) * 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
AU2003222642A1 (en) * 2002-05-10 2003-11-11 Chrysalis Technologies Incorporated Aerosol generator for drug formulation and methods of generating aerosol
DK1539286T3 (en) 2002-09-16 2015-04-27 Sanofi Sa INHALATOR FOR POWDER-DEFINED NAME MEDICAL SUBSTANCES
DE60315492T2 (de) * 2002-10-22 2008-04-24 Glaxo Group Ltd., Greenford Medizinisch verwendbare arylethanolamin verbindungen
US7442839B2 (en) 2002-10-28 2008-10-28 Glaxo Group Limited Phenethanolamine derivative for the treatment of respiratory diseases
GB0303396D0 (en) * 2003-02-14 2003-03-19 Glaxo Group Ltd Medicinal compounds
FR2858867B1 (fr) * 2003-08-12 2005-11-04 Valois Sa Indicateur de doses pour dispositif de distribution de produit fluide
GB0324886D0 (en) * 2003-10-24 2003-11-26 Glaxo Group Ltd Medicinal compounds
EP1686960A4 (en) * 2003-10-28 2007-03-07 Glaxo Group Ltd INHALABLE PHARMACEUTICAL PREPARATIONS EMPLOYING LACTOSE ANHYDRATE, AND METHODS OF ADMINISTERING SAID PREPARATIONS
GB0329182D0 (en) * 2003-12-17 2004-01-21 Glaxo Group Ltd Chemical compounds
BRPI0509382A (pt) * 2004-04-02 2007-09-18 Glaxo Group Ltd processo para a preparação de um sal monocloridrato de composto, monocloridrato cristalino, processo para obter monocloridrato cristalino, método para a profilaxia ou o tratamento de uma condição clìnica em um mamìfero, uso de monocloridrato cristalino, formulação farmacêutica, e, combinação
WO2005102429A1 (en) 2004-04-21 2005-11-03 Innovata Biomed Limited Inhaler
GB0409197D0 (en) 2004-04-24 2004-05-26 Innovata Biomed Ltd Device
CN101137625A (zh) * 2005-01-11 2008-03-05 葛兰素集团有限公司 β2肾上腺素能激动剂的肉桂酸盐
EP1858528A2 (en) * 2005-02-10 2007-11-28 Glaxo Group Limited Process for crystallizing lactose particles for use in pharmaceutical formulations
EP1848444B1 (en) 2005-02-10 2016-11-09 Glaxo Group Limited Processes for making lactose utilizing pre-classification techniques and pharmaceutical formulations formed therefrom
PE20061351A1 (es) 2005-03-25 2007-01-14 Glaxo Group Ltd COMPUESTOS 8H-PIRIDO[2,3-d]PIRIMIDIN-7-ONA 2,4,8-TRISUSTITUIDOS COMO INHIBIDORES DE LA QUINASA CSBP/RK/p38
PE20100741A1 (es) 2005-03-25 2010-11-25 Glaxo Group Ltd COMPUESTOS DERIVADOS DE 3,4-DIHIDROPIRIMIDO[4,5-d]PIRIMIDIN-2(1H)-ONA COMO INHIBIDORES DE QUINASA p38
US20090308772A1 (en) * 2006-03-17 2009-12-17 Abrams William S Moisture-tight primary packaging for a dry powder inhaler
CN101484201B (zh) 2006-06-27 2011-06-15 大冢制药株式会社 粉末吸入器
GB0625303D0 (en) * 2006-12-19 2007-01-24 Jagotec Ag Improvements in and relating to metered dose inhalers
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
EP2058025B1 (en) * 2007-11-09 2014-09-03 Hitachi Ltd. Powder medicine administering apparatus
GB0800457D0 (en) * 2008-01-11 2008-02-20 Innovata Biomed Ltd Improvements in or relating to inhalers
DK2400950T3 (da) 2009-02-26 2019-07-29 Glaxo Group Ltd Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
EP2611422B1 (en) 2010-08-31 2018-10-31 GlaxoSmithKline Intellectual Property Development Limited Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
ES2546422T5 (es) 2010-08-31 2023-01-20 Glaxosmithkline Ip Dev Ltd Productos medicinales de inhalación de polvo seco que presentan propiedades de control de la humedad y procedimientos de administración de los mismos
JP2015522362A (ja) * 2012-07-20 2015-08-06 サノフィ・ソシエテ・アノニム 吸入デバイス用の計量要素および計量要素を含む吸入デバイス
EP2925328A1 (en) 2012-11-28 2015-10-07 Intercept Pharmaceuticals, Inc. Treatment of pulmonary disease
CA2948441A1 (en) 2014-05-12 2015-11-19 Glaxosmithkline Intellectual Property (No. 2) Limited Pharmaceutical compositions for treating infectious diseases
AR103891A1 (es) 2015-03-11 2017-06-14 Glaxosmithkline Ip Dev Ltd Proteínas de unión a tslp, ácido nucleico aislado que la codifica, vector y célula hospedadora que lo comprenden, método para producir dicha proteína, su uso para fabricar un medicamento, composición farmacéutica y kit que la comprenden
KR20180017038A (ko) 2015-06-15 2018-02-20 글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 Nrf2 조절제
CN108112251B (zh) 2015-06-15 2021-03-05 葛兰素史克知识产权发展有限公司 Nrf2调节剂
EP3307729B1 (en) 2015-06-15 2020-09-02 GlaxoSmithKline Intellectual Property Development Limited Nrf2 regulators
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
US10364256B2 (en) 2015-10-06 2019-07-30 Glaxosmithkline Intellectual Property Development Limited Biaryl pyrazoles as NRF2 regulators
EP3371167A1 (en) 2015-10-06 2018-09-12 GlaxoSmithKline Intellectual Property Development Limited Arylcyclohexyl pyrazoles as nrf2 regulators
JP2019532054A (ja) 2016-09-20 2019-11-07 グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ （Ｎｏ．２） Ｌｉｍｉｔｅｄ Ｔｒｐｖ４拮抗薬
JP7106528B2 (ja) 2016-09-20 2022-07-26 グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッド Ｔｒｐｖ４拮抗薬
TW201825458A (zh) 2016-09-20 2018-07-16 英商葛蘭素史克智慧財產（第二）有限公司 Ｔｒｐｖ４拮抗劑
WO2018104766A1 (en) 2016-12-06 2018-06-14 Glaxosmithkline Intellectual Property Development Limited 3-(2,3-dihydro-1h-inden-5-yl)propanoic acid derivatives and their use as nrf2 regulators
JP2020500919A (ja) 2016-12-12 2020-01-16 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｎｒｆ２レギュレーターとしての３−カルボン酸ピロール
JP2020500918A (ja) 2016-12-12 2020-01-16 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｎｒｆ２レギュレーターとしてのｎ−アリールピラゾール
JP2020502136A (ja) 2016-12-14 2020-01-23 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｎｒｆ２レギュレーターとしてのビスアリールアミド
JP2020502129A (ja) 2016-12-14 2020-01-23 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ Ｎｒｆ２アクチベーターとしての３−オキソ−１，４−ジアゼピニル化合物
EP3555078B1 (en) 2016-12-14 2024-03-27 GlaxoSmithKline Intellectual Property Development Limited Bisaryl heterocycles as nrf2 activators
EP3555082B1 (en) 2016-12-15 2022-01-26 GlaxoSmithKline Intellectual Property Development Limited Ether linked triazoles as nrf2 regulators
BR112019012300A2 (pt) 2016-12-15 2019-11-12 Glaxosmithkline Ip Dev Ltd ativadores nrf2
WO2019116231A1 (en) 2017-12-11 2019-06-20 Glaxosmithkline Intellectual Property Development Limited Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
JP2021505636A (ja) 2017-12-11 2021-02-18 グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ 急性肺傷害、急性呼吸促迫症候群および多臓器不全症候群の処置のためのｎｒｆ２アクチベーター
GB201720989D0 (en) 2017-12-15 2018-01-31 Glaxosmithkline Ip Dev Ltd Chemical compounds
CN111868063B (zh) 2018-01-17 2023-08-01 葛兰素史克知识产权开发有限公司 PI4KIIIβ抑制剂
EP3796906A1 (en) 2018-05-23 2021-03-31 GlaxoSmithKline Intellectual Property Management Limited Indanes as nrf2 activators
GB201908536D0 (en) 2019-06-13 2019-07-31 Glaxosmithkline Ip Dev Ltd Compounds
EP4138884A1 (en) 2020-04-20 2023-03-01 Sorrento Therapeutics, Inc. Pulmonary administration of ace2 polypeptides
WO2022175425A1 (en) 2021-02-22 2022-08-25 Glaxosmithkline Intellectual Property Development Limited Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
WO2023117929A1 (en) * 2021-12-21 2023-06-29 Chiesi Farmaceutici S.P.A. Powder inhaler

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1587657A (es) * 1968-08-01 1970-03-27
US3662915A (en) * 1970-10-08 1972-05-16 Dougherty Bros Tamper proof package
US3840152A (en) * 1973-06-18 1974-10-08 None Such Enterprises Inc Sealable and resealable container
US4491238A (en) * 1983-12-12 1985-01-01 Tobolt Michael J Receptacle having a plug closure
US4762248A (en) * 1987-05-11 1988-08-09 Plastic Technologies Tamper resistant wide mouth package
US5718355A (en) * 1989-02-03 1998-02-17 Senetics, Inc. Indicator device responsive to axial force for use with inhaler
US5421482A (en) * 1989-02-03 1995-06-06 Senetics, Inc. Indicator device responsive to axial force
SE466684B (sv) * 1989-03-07 1992-03-23 Draco Ab Anordning vid en inhalator samt foerfarande foer att med anordningen registrera medicinering med inhalator
CH682227A5 (en) * 1990-11-23 1993-08-13 Edy Scheller Ag Plastics bottle closure - has closure part fixed to bottle neck with lower securing strip preventing unauthorised removal from neck
US5394868A (en) * 1992-06-25 1995-03-07 Schering Corporation Inhalation device for powdered medicaments
DE69331635T2 (de) * 1992-11-12 2002-10-31 Minnesota Mining & Mfg Pulverinhalator
CZ287848B6 (en) * 1992-12-18 2001-02-14 Schering Corp Inhalator of powder substances
US5524613A (en) * 1993-08-25 1996-06-11 Habley Medical Technology Corporation Controlled multi-pharmaceutical inhaler
BR9407608A (pt) * 1993-09-22 1997-01-14 Senetics Inc Dispositivo indicador e dispositivo para indicar a liberação de medicamento em aerossol
MX9701957A (es) * 1994-09-16 1998-02-28 Glaxo Wellcome Lab Sa Dispostivo de inhalacion.

Also Published As

Publication number Publication date
PL334447A1 (en) 2000-02-28
AP2002002693A0 (en) 2002-12-31
EA001291B1 (ru) 2000-12-25
WO1998030262A2 (en) 1998-07-16
NO993348D0 (no) 1999-07-07
TW404843B (en) 2000-09-11
CZ2000298A3 (cs) 2000-05-17
NO993348L (no) 1999-07-07
EP0954348B1 (en) 2004-10-20
ATE303838T1 (de) 2005-09-15
IL130687A0 (en) 2000-06-01
EA001286B1 (ru) 2000-12-25
TR199901582T2 (xx) 1999-09-21
ATE279954T1 (de) 2004-11-15
HRP980382A2 (en) 1999-10-31
DE69831517D1 (de) 2005-10-13
GB9700226D0 (en) 1997-02-26
AP9901596A0 (en) 1999-09-30
CN1478557A (zh) 2004-03-03
NZ336507A (en) 2001-09-28
CO5080756A1 (es) 2001-09-25
CA2277150A1 (en) 1998-07-16
AP1165A (en) 2003-06-30
DE69827112D1 (de) 2004-11-25
ID22851A (id) 1999-12-09
HUP0000885A3 (en) 2001-02-28
DE69831517T2 (de) 2006-06-08
PL187248B1 (pl) 2004-06-30
AR011372A1 (es) 2000-08-16
JP2001507966A (ja) 2001-06-19
AP1259A (en) 2004-04-23
HUP0000885A2 (hu) 2000-08-28
IS5103A (is) 1999-06-30
PL187815B1 (pl) 2004-10-29
BR9806864A (pt) 2000-04-18
EP1378260B1 (en) 2005-09-07
EA200000229A1 (ru) 2000-08-28
EP1378260A2 (en) 2004-01-07
WO1998030262A3 (en) 1998-10-15
CN1249694A (zh) 2000-04-05
HU222771B1 (hu) 2003-10-28
AR017446A2 (es) 2001-09-05
EP0954348A2 (en) 1999-11-10
YU32399A (sh) 2001-05-28
PE20030179A1 (es) 2003-04-07
TR200000032T2 (tr) 2000-07-21
KR20000069973A (ko) 2000-11-25
US6321747B1 (en) 2001-11-27
EA199900515A1 (ru) 2000-04-24
DE69827112T2 (de) 2005-03-24
EP1378260A3 (en) 2004-01-21
IL130687A (en) 2003-09-17
HRP980382B1 (en) 2002-06-30

Similar Documents

Publication Publication Date Title
PE39599A1 (es) Dispositivo de inhalacion
MX9300908A (es) Dispositivo dosificador.
AR064901A2 (es) Una pelicula consumible adaptada para disolverse en la boca de un consumidor
AR009552A1 (es) Un articulo absorbente descartable que tiene un dique de contencion
GR3029719T3 (en) Powder inhaler using powder carriers with regular surface microfeatures.
GB2359987A (en) Interdental brush
PE98899A1 (es) Un sistema de suministro para una sustancia para el cuidado bucal que utiliza una tira de material que tiene baja rigidez en flexion
CO4940364A1 (es) Sistema de suministro de una substancia blanqueadora de dientes usando una tira de material que tiene baja rigidez en flexion
AR008957A1 (es) Inhalador de polvo para administrar polvo por inhalacion
MXPA04005969A (es) Conector medico.
MXPA00008174A (es) Mejoras en los dispositivos de distribucion de medicamento.
ES2155243T3 (es) Dispositivo para el maquillaje de los labios.
MX9305473A (es) Dispositivo distribuidor de medicamentos.
WO1999032074A3 (en) Oral care composition
ES2184949T3 (es) Vendaje medico de forma anatomica.
KR101850625B1 (ko) 구강 건강용 마우스피스
HUP0003713A2 (hu) Króm és biotin tartalmú gyógyászati készítmény II típusú diabétesz kezelésére
MXPA03003911A (es) Polvo en contra de los hongos que tiene propiedades de excipiente mejoradas.
AR037480A1 (es) Compuesto resistente al agua altamente respirable
HUP0101096A2 (hu) Orrspray-készülék elasztomer szeleppel
GB2372454B (en) Medical respiratory apparatus
ATE328624T1 (de) Verwendung einer spritze für medizinische zwecke in verbindung mit einer transportvorrichtung
MXPA05012749A (es) Articulo absorbente modular.
ECSP982580A (es) Dispositivo de inhalacion
UY25081A1 (es) Dispositivo de inhalacion

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed